title: Monitoring of acute myeloid leukemia patients after allogeneic stem cell transplantation employing semi-automated CD34+ donor cell chimerism analysis.
abstract: Determination of donor chimerism profiles in blood or bone marrow from patients with allogeneic stem cell transplantation (SCT) is useful for monitoring engraftment or predicting relapse, when specific molecular markers are lacking. CD34+ donor cell chimerism (DCC) analysis in peripheral blood samples from CD34+ acute myeloid leukemia (AML) and myleodysplastic syndrome (MDS) patients proved to be a highly sensitive diagnostic tool that is useful to detect imminent relapse significantly earlier compared to total white blood cell donor cell chimerism monitoring. However, flow-cytometric enrichment of CD34+ cells requires high efforts to human resources and equipment. We present a novel semi-automated CD34+ DCC analysis procedure-employing a magnetic cell-enrichment device, DNA extraction, and short tandem repeat profiling-without the need for flow-cytometric cell sorting. Monitoring 85 patients with AML and MDS over a period of 4 years 24 relapses were detected. Semi-automated peripheral blood CD34+ DCC was diminished below 80 % in all cases of systemic relapse. Significant decrease of the CD34+ DCC value was detected 29-42 days before overt cytological relapse. Our method provides a rapid and sensitive tool for monitoring AML and MDS patients after allogeneic SCT with regard to engraftment and early detection of relapse. Here, we propose a novel semi-automated procedure for CD34+ DCC analysis after allogeneic SCT that is simple, reliable, and therefore applicable in all hematologic laboratories.
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, University Hospital Giessen and Marburg, Campus Marburg, Baldingerstraße, 35043, Marburg, Germany.
authors.forename: Joerg Christian
authors.initials: JC
authors.lastname: Hoffmann
authors.forename: Kathleen
authors.initials: K
authors.lastname: Stabla
authors.forename: Andreas
authors.initials: A
authors.lastname: Burchert
authors.forename: Thorsten
authors.initials: T
authors.lastname: Volkmann
authors.forename: Martin
authors.initials: M
authors.lastname: Bornhäuser
authors.forename: Christian
authors.initials: C
authors.lastname: Thiede
authors.forename: Andreas
authors.initials: A
authors.lastname: Neubauer
authors.forename: Cornelia
authors.initials: C
authors.lastname: Brendel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D064591:Allografts; D018952:Antigens, CD34 / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy; D033581:Stem Cell Transplantation; D018183:Transplantation Chimera / Q000097:blood*
chemical_list: D018952:Antigens, CD34